1
|
Petrova NV, Kashirskaya NY, Vasilyeva TA, Timkovskaya EE, Voronkova AY, Shabalova LA, Kondratyeva EI, Sherman VD, Novoselova OG, Kapranov NI, Zinchenko RA, Ginter EK, Makaov AKM, Kerem B. High prevalence of W1282x mutation in cystic fibrosis patients from Karachay-Cherkessia. J Cyst Fibros 2017; 15:e28-32. [PMID: 26948992 DOI: 10.1016/j.jcf.2016.02.003] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2015] [Revised: 02/02/2016] [Accepted: 02/03/2016] [Indexed: 11/16/2022]
Abstract
Cystic fibrosis (CF; OMIM #219700) is a common autosomal recessive disease. The spectrum and frequency of CFTR mutations vary significantly in different populations and ethnic groups. A genetic epidemiological study was conducted in the indigenous ethnic group of people known as the Karachais. They live in the Republic of Karachay-Cherkessia, which lies in the northwest of Russia's North Caucasus region. Karachai's are Turkic-speaking and consist of 194 thousand people (approximately 40% of the population of the Republic). Molecular genetic analysis was performed in 10 unrelated Karachai families with CF patients from three districts in the Republic. A high frequency of W1282X mutation was found (18 of 20 mutant alleles): eight patients were homozygous for the W1282X mutation, and two were compound heterozygous (the second alleles were R1066C and R709X). Analysis for 13 common CF mutations in the sample of 142 healthy Karachais identified two 1677delTA and two W1282X mutation carriers. Thus, the most common CFTR mutation, F508del, was not detected among the CF patients or in healthy Karachais. The most frequent mutation among Karachai patients is W1282X (90%). Its frequency in healthy Karachais is approximately 0.007. Haplotype analysis using the CFTR intragene DNA markers IVS1CA, IVS6aGATT, IVS8CA and IVS17bCA showed that the origins of the W1282X mutation in Karachay-Cherkessia and the Eastern European part of Russia are different.
Collapse
Affiliation(s)
- N V Petrova
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation.
| | - N Yu Kashirskaya
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation.
| | - T A Vasilyeva
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation
| | - E E Timkovskaya
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation.
| | - A Yu Voronkova
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation.
| | - L A Shabalova
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation.
| | - E I Kondratyeva
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation.
| | - V D Sherman
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation.
| | - O G Novoselova
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation.
| | - N I Kapranov
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation.
| | - R A Zinchenko
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation; Pirogov Russian National Research Medical University, Ostrovityanova St., 1, Moscow 117997, Russian Federation; Moscow State University of Medicine and Dentistry, Delegatskaya St., 20 bld. 1, Moscow 127473, Russian Federation.
| | - E K Ginter
- Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechje St., 1, Moscow 115478, Russian Federation; Russian Medical Academy of Postgraduate Education, Barrikadnaya St., 2/1, Moscow 125993, Russian Federation.
| | - A Kh-M Makaov
- Municipal Budgetary Health Care Institution, Habezskaya Central District Hospital, Karachay-Cherkessia Republic, Habez, 6, Bolnichnaya Str., Russian Federation.
| | - B Kerem
- Department of Genetics, The Hebrew University of Jerusalem, 91904, Israel.
| |
Collapse
|
2
|
Stanke F, Becker T, Kumar V, Hedtfeld S, Becker C, Cuppens H, Tamm S, Yarden J, Laabs U, Siebert B, Fernandez L, Macek M, Radojkovic D, Ballmann M, Greipel J, Cassiman JJ, Wienker TF, Tümmler B. Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia. J Med Genet 2010; 48:24-31. [PMID: 20837493 PMCID: PMC3003880 DOI: 10.1136/jmg.2010.080937] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Background The cystic fibrosis (CF) basic defect, caused by dysfunction of the apical chloride channel CFTR in the gastrointestinal and respiratory tract epithelia, has not been employed so far to support the role of CF modifier genes. Methods Patients were selected from 101 families with a total of 171 F508del-CFTR homozygous CF patients to identify CF modifying genes. A candidate gene based association study of 52 genes on 16 different chromosomes with a total of 182 genetic markers was performed. Differences in haplotype and/or diplotype distribution between case and reference CF subpopulations were analysed. Results Variants at immunologically relevant genes were associated with the manifestation of the CF basic defect (0.01<Praw<0.0001 at IL1B, TLR9, TNFα, CD95, STAT3 and TNFR). The intragenic background of F508del-CFTR chromosomes determined disease severity and manifestation of the basic defect (Praw=0.0009). Allele distributions comparing transmitted and non-transmitted alleles were distorted at several loci unlinked to CFTR. Conclusions The inherited capabilities of the innate and adaptive immune system determine the manifestation of the CF basic defect. Variants on F508del-CFTR chromosomes contribute to the observed patient-to-patient variability among F508del-CFTR homozygotes. A survivor effect, manifesting as a transmission disequilibrium at many loci, is consistent with the improvement of clinical care over the last decades, resulting in a depletion of risk alleles at modifier genes. Awareness of non-genetic factors such as improvement of patient care over time is crucial for the interpretation of CF modifier studies.
Collapse
Affiliation(s)
- Frauke Stanke
- Department of Pediatrics, Hannover Medical School, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
An ancient autosomal haplotype bearing a rare achromatopsia-causing founder mutation is shared among Arab Muslims and Oriental Jews. Hum Genet 2010; 128:261-7. [DOI: 10.1007/s00439-010-0846-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2010] [Accepted: 06/02/2010] [Indexed: 10/19/2022]
|
4
|
Linde L, Kerem B. Introducing sense into nonsense in treatments of human genetic diseases. Trends Genet 2008; 24:552-63. [PMID: 18937996 DOI: 10.1016/j.tig.2008.08.010] [Citation(s) in RCA: 146] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2008] [Revised: 08/18/2008] [Accepted: 08/19/2008] [Indexed: 11/26/2022]
Abstract
Approximately one-third of alleles causing genetic diseases carry premature termination codons (PTCs), which lead to the production of truncated proteins. The past decade has seen considerable interest in therapeutic approaches aimed at readthrough of in-frame PTCs to enable synthesis of full-length proteins. However, attempts to readthrough PTCs in many diseases resulted in variable effects. Here, we focus on the efforts of such therapeutic approaches in cystic fibrosis and Duchenne muscular dystrophy and discuss the factors contributing to successful readthrough and how the nonsense-mediated mRNA decay (NMD) pathway regulates this response. A deeper understanding of the molecular basis for variable response to readthrough of PTCs is necessary so that appropriate therapies can be developed to treat many human genetic diseases caused by PTCs.
Collapse
Affiliation(s)
- Liat Linde
- Department of Genetics, The Life Sciences Institute, Givat Ram Campus, The Hebrew University, Jerusalem 91904, Israel
| | | |
Collapse
|
5
|
Poolman EM, Galvani AP. Evaluating candidate agents of selective pressure for cystic fibrosis. J R Soc Interface 2007; 4:91-8. [PMID: 17015291 PMCID: PMC2358959 DOI: 10.1098/rsif.2006.0154] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Cystic fibrosis is the most common lethal single-gene mutation in people of European descent, with a carrier frequency upwards of 2%. Based upon molecular research, resistances in the heterozygote to cholera and typhoid fever have been proposed to explain the persistence of the mutation. Using a population genetic model parameterized with historical demographic and epidemiological data, we show that neither cholera nor typhoid fever provided enough historical selective pressure to produce the modern incidence of cystic fibrosis. However, we demonstrate that the European tuberculosis pandemic beginning in the seventeenth century would have provided sufficient historical, geographically appropriate selective pressure under conservative assumptions. Tuberculosis has been underappreciated as a possible selective agent in producing cystic fibrosis but has clinical, molecular and now historical, geographical and epidemiological support. Implications for the future trajectory of cystic fibrosis are discussed. Our result supports the importance of novel investigations into the role of arylsulphatase B deficiency in cystic fibrosis and tuberculosis.
Collapse
Affiliation(s)
- Eric M Poolman
- Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College Street, Room 147, New Haven, CT 06520, USA.
| | | |
Collapse
|
6
|
Modiano G, Ciminelli BM, Pignatti PF. Cystic fibrosis and lactase persistence: a possible correlation. Eur J Hum Genet 2006; 15:255-9. [PMID: 17180122 DOI: 10.1038/sj.ejhg.5201749] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Affiliation(s)
- Guido Modiano
- Department of Biology, University of Roma, Tor Vergata, Italy.
| | | | | |
Collapse
|
7
|
Nectoux J, Audrezet MP, Viel M, Leroy C, Raguenes O, Ferec C, Lesure JF, Davy N, Renouil M, Cartault F, Bienvenu T. A Frequent Large Rearrangement in theCFTRGene in Cystic Fibrosis Patients from Reunion Island. ACTA ACUST UNITED AC 2006; 10:208-14. [PMID: 17020473 DOI: 10.1089/gte.2006.10.208] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Reunion Island is a French province, 800 km east of Madagascar and 200 km west of Mauritius. On Reunion Island, the birth prevalence of cystic fibrosis (CF) is particularly high in the population of European origin, approximately 1:1000. In a previous study, we demonstrated that the screening of the 27 exons of the CF transmembrane conductance regulator (CFTR) gene by denaturing high-pressure liquid chromatography (DHPLC) in 114 CF families allowed the detection of about 93% of the molecular defects present on Reunion Island. Unidentified CF mutations may lie in introns or in regulatory regions that are not routinely investigated, or may correspond to gene rearrangements such as large, heterozygous deletions that escape detection using current PCR-based techniques. Using a combination of different methods (such as multiplex ligation-dependent probe amplification), 6 of the 13 unidentified CF alleles (46%) were found to harbor a deletion of 5288 bp, spanning from exon 17a to 18. Identification and examination of the breakpoint sequences showed that this deletion is different from the 3120+1kbdel8.6Kb previously found in the Palestinian Arabs. The chromosomes bearing IVS16+3316_IVS18+644del5288 did not have a common extragenic haplotype. Clinical evaluation of homozygotes (2 unrelated patients) and compound heterozygotes indicated that this deletion represents a severe mutation associated with positive sweat chloride test, pancreatic insufficiency, and early age at diagnosis.
Collapse
Affiliation(s)
- Juliette Nectoux
- Laboratoire de Biochimie et Génétique Moléculaire, Hôpital Cochin, Paris, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Pompei F, Ciminelli BM, Bombieri C, Ciccacci C, Koudova M, Giorgi S, Belpinati F, Begnini A, Cerny M, Des Georges M, Claustres M, Ferec C, Macek M, Modiano G, Pignatti PF. Haplotype block structure study of the CFTR gene. Most variants are associated with the M470 allele in several European populations. Eur J Hum Genet 2006; 14:85-93. [PMID: 16251901 DOI: 10.1038/sj.ejhg.5201498] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
An average of about 1700 CFTR (cystic fibrosis transmembrane conductance regulator) alleles from normal individuals from different European populations were extensively screened for DNA sequence variation. A total of 80 variants were observed: 61 coding SNSs (results already published), 13 noncoding SNSs, three STRs, two short deletions, and one nucleotide insertion. Eight DNA variants were classified as non-CF causing due to their high frequency of occurrence. Through this survey the CFTR has become the most exhaustively studied gene for its coding sequence variability and, though to a lesser extent, for its noncoding sequence variability as well. Interestingly, most variation was associated with the M470 allele, while the V470 allele showed an 'extended haplotype homozygosity' (EHH). These findings make us suggest a role for selection acting either on the M470V itself or through an hitchhiking mechanism involving a second site. The possible ancient origin of the V allele in an 'out of Africa' time frame is discussed.
Collapse
Affiliation(s)
- Fiorenza Pompei
- Department of Biology, University of Roma-Tor Vergata, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, Lerer B, Rietschel M, Trixler M, Maier W, Wildenauer DB. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003; 72:185-90. [PMID: 12474144 PMCID: PMC378624 DOI: 10.1086/345463] [Citation(s) in RCA: 270] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2002] [Accepted: 10/07/2002] [Indexed: 02/01/2023] Open
Abstract
Genetic variants in a gene on 6p22.3, dysbindin, have been shown recently to be associated with schizophrenia (Straub et al. 2002a). There is no doubt that replication in other independent samples would enhance the significance of this finding considerably. Since the gene is located in the center of the linkage peak on chromosome 6p that we reported earlier, we decided to test six of the most positive DNA polymorphisms in a sib-pair sample and in an independently ascertained sample of triads comprising 203 families, including the families for which we detected linkage on chromosome 6p. Evidence for association was observed in the two samples separately as well as in the combined sample (P=.00068 for SNP rs760761). Multilocus haplotype analysis increased the significance further to .00002 for a two-locus haplotype and to .00001 for a three-locus haplotype. Estimation of frequencies for six-locus haplotypes revealed one common haplotype with a frequency of 73.4% in transmitted, and only 57.6% in nontransmitted, parental haplotypes. All other six-locus haplotypes occurring at a frequency of >1% were less often transmitted than nontransmitted. Our results represent a first successful replication of linkage disequilibrium in psychiatric genetics detected in a region with previous evidence of linkage and will encourage the search for causes of schizophrenia by the genetic approach.
Collapse
Affiliation(s)
- Sibylle G. Schwab
- Molecular Genetics Laboratory, Department of Psychiatry, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto; State Mental Hospital, Haar, Germany; Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem; Zentralinstitut für Seelische Gesundheit, Mannheim; and Department of Psychiatry, University of Pecs, Pecs, Hungary
| | - Michael Knapp
- Molecular Genetics Laboratory, Department of Psychiatry, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto; State Mental Hospital, Haar, Germany; Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem; Zentralinstitut für Seelische Gesundheit, Mannheim; and Department of Psychiatry, University of Pecs, Pecs, Hungary
| | - Stephanie Mondabon
- Molecular Genetics Laboratory, Department of Psychiatry, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto; State Mental Hospital, Haar, Germany; Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem; Zentralinstitut für Seelische Gesundheit, Mannheim; and Department of Psychiatry, University of Pecs, Pecs, Hungary
| | - Joachim Hallmayer
- Molecular Genetics Laboratory, Department of Psychiatry, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto; State Mental Hospital, Haar, Germany; Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem; Zentralinstitut für Seelische Gesundheit, Mannheim; and Department of Psychiatry, University of Pecs, Pecs, Hungary
| | - Margitta Borrmann-Hassenbach
- Molecular Genetics Laboratory, Department of Psychiatry, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto; State Mental Hospital, Haar, Germany; Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem; Zentralinstitut für Seelische Gesundheit, Mannheim; and Department of Psychiatry, University of Pecs, Pecs, Hungary
| | - Margot Albus
- Molecular Genetics Laboratory, Department of Psychiatry, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto; State Mental Hospital, Haar, Germany; Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem; Zentralinstitut für Seelische Gesundheit, Mannheim; and Department of Psychiatry, University of Pecs, Pecs, Hungary
| | - Bernard Lerer
- Molecular Genetics Laboratory, Department of Psychiatry, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto; State Mental Hospital, Haar, Germany; Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem; Zentralinstitut für Seelische Gesundheit, Mannheim; and Department of Psychiatry, University of Pecs, Pecs, Hungary
| | - Marcella Rietschel
- Molecular Genetics Laboratory, Department of Psychiatry, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto; State Mental Hospital, Haar, Germany; Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem; Zentralinstitut für Seelische Gesundheit, Mannheim; and Department of Psychiatry, University of Pecs, Pecs, Hungary
| | - Matyas Trixler
- Molecular Genetics Laboratory, Department of Psychiatry, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto; State Mental Hospital, Haar, Germany; Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem; Zentralinstitut für Seelische Gesundheit, Mannheim; and Department of Psychiatry, University of Pecs, Pecs, Hungary
| | - Wolfgang Maier
- Molecular Genetics Laboratory, Department of Psychiatry, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto; State Mental Hospital, Haar, Germany; Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem; Zentralinstitut für Seelische Gesundheit, Mannheim; and Department of Psychiatry, University of Pecs, Pecs, Hungary
| | - Dieter B. Wildenauer
- Molecular Genetics Laboratory, Department of Psychiatry, and Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto; State Mental Hospital, Haar, Germany; Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem; Zentralinstitut für Seelische Gesundheit, Mannheim; and Department of Psychiatry, University of Pecs, Pecs, Hungary
| |
Collapse
|
10
|
Orozco L, González L, Chávez M, Velázquez R, Lezana JL, Saldaña Y, Villarreal T, Carnevale A. XV-2c/KM-19 haplotype analysis of cystic fibrosis mutations in Mexican patients. AMERICAN JOURNAL OF MEDICAL GENETICS 2001; 102:277-81. [PMID: 11484207 DOI: 10.1002/ajmg.1465] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
We analyzed 97 unrelated Mexican cystic fibrosis (CF) patients and their first-degree relatives to study the association of XV2C/TaqI/KM19/PstI haplotypes with CF mutations in this population. Haplotype phases could be established in 148 CF and 110 normal chromosomes, and haplotype distributions of normal and CF chromosomes differed significantly (P < 0.001). DeltaF508 and G542X mutations accounted for 56% of CF chromosomes and were found to be associated with haplotype B in 97.2% and 72.7% of chromosomes, respectively. The haplotype distribution of CF chromosomes carrying other rare and unknown mutations was similar to that of normal chromosomes (P > 0.05), haplotypes A and C being the most frequent. This is in accordance with the extensive heterogeneity and the spectrum of mutations reported in Mexican CF patients. We also report the haplotype distribution of all informative chromosomes bearing rare mutations; some were found to be associated with previously reported haplotypes, whereas others were found on different haplotypes. Recombination or recurrence of mutations may explain these different associations, although other intragenic markers must be used to better understand the origin and dispersion of CF mutations in our country. XK haplotype analysis allowed carrier detection among sibs in 24.3% of families, showing that this method may be useful for carrier detection in populations with high allelic heterogeneity.
Collapse
Affiliation(s)
- L Orozco
- Molecular Biology Laboratory, Department of Research in Human Genetics, National Institute of Pediatrics, Mexico City, Mexico.
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Permutt MA, Wasson JC, Suarez BK, Lin J, Thomas J, Meyer J, Lewitzky S, Rennich JS, Parker A, DuPrat L, Maruti S, Chayen S, Glaser B. A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes 2001; 50:681-5. [PMID: 11246891 DOI: 10.2337/diabetes.50.3.681] [Citation(s) in RCA: 110] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
A total of 896 individuals of Ashkenazi Jewish descent were ascertained in Israel from 267 multiplex families, including 472 sib-pairs affected with type 2 diabetes. A genome-wide scan with average marker spacing of 9.5 cM revealed five regions on four chromosomes (4q, 8q, 14q, and 20q) that exhibited nominal evidence for linkage (P < 0.05). The highest observed nonparametric linkage Z score was 2.41 (equivalent to a logarithm of odds score of 1.26) at marker D4S1501. A maximal signal, with a Z score of 2.05, was observed on chromosome 20 near marker D20S195, and another on 20p near marker D20S103 (Z 1.80). A single marker on chromosome 8 (D8S593) and two adjacent markers on chromosome 14 (D14S749 and D14S605) also attained evidence of linkage. To explore the hypothesis that the signals on chromosomes 4 and 20 are differentially attributable to variation in BMI or age of onset, an ordered subset analysis was conducted. This analysis revealed that only when the families were ranked by BMI (in increasing order) did a subset attain nominal significance, and only for chromosome 4. The findings reported here lend credence to the hypothesis, now supported by four studies of Caucasian populations and most recently by a combined analysis of 1,852 pedigrees, that a type 2 diabetes susceptibility locus resides on chromosome 20q. This population, because of its unique genetic attributes, may facilitate identification of this and other genes contributing to type 2 diabetes.
Collapse
Affiliation(s)
- M A Permutt
- Division of Metabolism, Endocrinology, and Diabetes, Washington University Medical School, St. Louis, Missouri 63110, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Chiba-Falek O, Parad RB, Kerem E, Kerem B. Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation. Am J Respir Crit Care Med 1999; 159:1998-2002. [PMID: 10351951 DOI: 10.1164/ajrccm.159.6.9808012] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Disease severity varies among cystic fibrosis (CF) patients carrying the same cystic fibrosis transmembrane conductance regulator (CFTR) genotype and among organs of the same individual. It has been shown that the class V splicing mutation 3849 + 10 kb C--> T produces both normal and aberrantly spliced CFTR transcripts. We analyzed the levels of normal CFTR messenger RNA (mRNA) in different organs of an aborted fetus carrying the 3849 + 10 kb C--> T mutation, and found that they correlated with the histopathologic changes observed in these organs. We performed semiquantitative nondifferential reverse transcription-polymerase chain reaction on several organs from a 22-wk aborted CF fetus carrying the 3849 + 10 kb C--> T mutation. A very low level (1%) of normal CFTR mRNA was detected in the severely affected ileum of this fetus. Higher levels were found in the histopathologically unaffected trachea (17%), colon (19%), and lung (26%). Thus, as early as in utero, the regulation of alternative splice-site selection is an important mechanism underlying variable CF severity. Understanding of the mechanisms regulating alternative splicing in different tissues will contribute to potential therapy for patients carrying splicing mutations in CF and other human disease genes.
Collapse
Affiliation(s)
- O Chiba-Falek
- Department of Genetics, The Hebrew University, Jerusalem, Israel
| | | | | | | |
Collapse
|
13
|
Chiba-Falek O, Kerem E, Shoshani T, Aviram M, Augarten A, Bentur L, Tal A, Tullis E, Rahat A, Kerem B. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation. Genomics 1998; 53:276-83. [PMID: 9799593 DOI: 10.1006/geno.1998.5517] [Citation(s) in RCA: 62] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Disease severity varies among cystic fibrosis (CF) patients carrying the same CFTR genotype. Here we studied the mechanism underlying disease variability in individuals carrying a splicing CFTR mutation, 3849+10 kb C-->T. This mutation was shown to produce both correctly and aberrantly spliced CFTR transcripts containing an additional cryptic exon. Semiquantitative nondifferential RT-PCR showed considerable variability in the level (0-28%) of aberrantly spliced RNA transcribed from the 3849+10 kb C-->T mutation in nasal epithelium from 10 patients. A significant inverse correlation was found between the level of the aberrantly spliced CFTR transcripts and pulmonary function, expressed as FEV1 (r = 0.92, P < 0.0001). Patients with normal pulmonary function (FEV1 > 80% predicted) had lower levels of aberrantly spliced CFTR RNA (0 to 3%) than those with FEV1 < 80%, (9 to 28% aberrantly spliced RNA). Only aberrantly spliced CFTR RNA was detected in the lung of a patient with severe lung disease who underwent lung transplantation. Our results show that the severity of CF lung disease correlates with insufficiency of normal CFTR RNA. Thus, the regulation of alternative splice site selection may be an important mechanism underlying partial penetrance in CF. Further understanding of this regulation will contribute to potential therapy for patients carrying splicing mutations in human disease genes.
Collapse
Affiliation(s)
- O Chiba-Falek
- Department of Genetics, The Hebrew University of Jerusalem, Jerusalem, Israel
| | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Dörk T, El-Harith EH, Stuhrmann M, Macek M, Egan M, Cutting GR, Tzetis M, Kanavakis E, Carles S, Claustres M, Padoa C, Ramsay M, Schmidtke J. Evidence for a common ethnic origin of cystic fibrosis mutation 3120+1G-->A in diverse populations. Am J Hum Genet 1998; 63:656-62. [PMID: 9683582 PMCID: PMC1377292 DOI: 10.1086/301950] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
|
15
|
Kerem E, Kalman YM, Yahav Y, Shoshani T, Abeliovich D, Szeinberg A, Rivlin J, Blau H, Tal A, Ben-Tur L. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel. Hum Genet 1995; 96:193-7. [PMID: 7635469 DOI: 10.1007/bf00207378] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
The incidence of cystic fibrosis (CF) and the frequency of disease-causing mutations varies among different ethnic and geographic populations. The Jewish population around the world is comprised of two major ethnic groups; Ashkenazi and non-Ashkenazi. The latter is further classified according to country of origin. In this study, we analyzed the incidence of CF and the distribution of CF mutations in the general Jewish population in Israel and in most of the Jewish ethnic subgroups. The disease frequency varies considerably among the latter. Among Ashkenazi Jews, the frequency of CF is 1:3300, which is similar to the frequency in most Caucasian populations. Among non-Ashkenazi Jews, the disease occurs at a similar frequency among Jews from Libya (1:2700), Georgia (1:2700), Greece and Bulgaria (1:2400), but is rare in Jews from Yemen (1:8800), Morocco (1:15000), Iraq (1:32000), and Iran (1:39000). So far, only 12 mutations have been identified in Israeli Jews, and this enables the identification of 91% of the CF chromosomes in the entire Jewish CF population. However, in each Jewish ethnic group, the disease is caused by a different repertoire of mutations. The frequency of identified mutations is high in Ashkenazi Jews (95%), and in Jews originating from Tunisia (100%), Libya (91%), Turkey (90%), and Georgia (88%). However, a lower frequency of mutations can be identified in Moroccan (85%), Egyptian (50%), and Yemenite (0%) Jews. For genetic counseling of a Jewish individual, it is necessary to calculate the residual risk according to ethnic origin. Carrier screening of healthy Jewish individuals is currently feasible for Ashkenazi Tunisian, Libyan, Turkish, and Georgian Jews. These results provide the required information for genetic counseling of Jewish CF families and screening programs of Jewish populations worldwide.
Collapse
Affiliation(s)
- E Kerem
- Department of Genetics, Hebrew University Jerusalem, Israel
| | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Novelli G, Sangiuolo F, Maceratesi P, Dallapiccola B. The up-to-date molecular genetics of cystic fibrosis. Biomed Pharmacother 1994; 48:455-63. [PMID: 7532022 DOI: 10.1016/0753-3322(94)90006-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Affiliation(s)
- G Novelli
- Cattedra di Genetica Umana, Università Cattolica del Sacro Cuore, Roma, Italy
| | | | | | | |
Collapse
|